Market Overview:
The global gastric mucosal protective agent market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of gastrointestinal diseases, rising awareness about the benefits of gastric mucosal protective agents, and technological advancements in the field of gastroenterology. Based on type, the global gastric mucosal protective agent market can be segmented into tablets, chewable tablets, and injectable agents. In terms of application, this market can be divided into hospitals, laboratories, and other end-users such as clinics and individual consumers. Geographically speaking, North America is anticipated to lead the global gastric mucosal protective agent market during the forecast period followed by Europe and Asia Pacific respectively.
Product Definition:
A gastric mucosal protective agent is a medication that helps protect the stomach lining from damage. This type of medication is often used to treat conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers. The importance of using a gastric mucosal protective agent is that it can help prevent further damage to the stomach lining and may help promote healing.
Tablet:
Tablet is a form of oral solid dosage drug delivery systems that are manufactured in the shape of a flat, hollow, round or square tablet. They can be administered orally and are available as film-coated tablets, effervescent tablets or enteric coated tablets. The drug content in tablet is usually 10 to 500 mg depending on the type of tablet being made. Some types contain more than one active ingredient while some others have but one active ingredient (mono-active ingredients).
Chewable:
Chewable and it’s usage in Gastric Mucosal Protective Agent market is a recent innovation in the drug delivery system. Chewable tablets or lozenges are rapidly gaining popularity as they enable patients to self-administer the medication without assistance from healthcare professionals. The growing demand for efficient drug administration techniques has led to an increase in R&D activities related to chewables, which is expected to boost growth over the forecast period.
Application Insights:
Based on application, the global market is segmented into hospital, laboratory and others. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to a high prevalence of chronic diseases such as diabetes and Cardiovascular Diseases (CVDs) which require gastric mucosal protective agents for effective treatment. In addition, increasing number of surgeries including gastric bypass procedures are further expected to propel demand over the forecast period.
The laboratory application segment is anticipated to witness lucrative growth over the forecast period owing to an increase in R&D activities pertaining to diagnosis of various chronic conditions such as cancer through Gastrointestinal Stromal Tumor (GIST) screening tests which require protection during biopsy or surgical removal of tumor tissues from patients¢â‚¬â„¢ body cavities. Thus, rising demand for GIST screening tests is expected drive demand for these products thereby contributing towards revenue growth during the study period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing incidence of stomach cancer and ulcers, rising adoption of minimally invasive surgeries, and high healthcare expenditure. In addition, growing awareness about gastric protectants among patients is anticipated to propel product demand in North America over the forecast period.
Asia Pacific is expected to witness lucrative growth over the coming years owing to factors such as improving economic conditions leading towards increased consumer disposable income levels resulting in higher health spending on treatment and prevention of stomach diseases coupled with rapidly developing healthcare infrastructure especially hospitals & clinics catering majorlyto low-income groups thus promoting usage rates for protective agents. Rising prevalence & incidence rateof cancers & other diseases caused by exposureto radiations at work are also contributing towards market growth in Asia Pacific countries such as Japan, China, India etc.
Growth Factors:
- Increasing incidence of gastric ulcers and other gastrointestinal disorders
- Growing awareness about the benefits of using gastric mucosal protective agents
- Rising demand for over-the-counter medications for the treatment of gastric ulcers and other gastrointestinal disorders
- Technological advancements in the manufacturing of gastric mucosal protective agents
- increasing research and development activities focused on developing new and improved formulations of gastric mucosal protective agents
Scope Of The Report
Report Attributes
Report Details
Report Title
Gastric Mucosal Protective Agent Market Research Report
By Type
Tablet, Chewable, Injectable
By Application
Hospital, Laboratory, Others
By Companies
Eisai, Pfizer, GSK, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Gastric Mucosal Protective Agent Market Report Segments:
The global Gastric Mucosal Protective Agent market is segmented on the basis of:
Types
Tablet, Chewable, Injectable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Laboratory, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Eisai
- Pfizer
- GSK
- Merck
Highlights of The Gastric Mucosal Protective Agent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Chewable
- Injectable
- By Application:
- Hospital
- Laboratory
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gastric Mucosal Protective Agent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gastric mucosal protective agent (GMP) is a medication that is used to protect the stomach lining from damage. It can be used to treat conditions such as Helicobacter pylori infection, ulcers, and gastritis.
Some of the major companies in the gastric mucosal protective agent market are Eisai, Pfizer, GSK, Merck.
The gastric mucosal protective agent market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Gastric Mucosal Protective Agent Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Gastric Mucosal Protective Agent Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Gastric Mucosal Protective Agent Market - Supply Chain
4.5. Global Gastric Mucosal Protective Agent Market Forecast
4.5.1. Gastric Mucosal Protective Agent Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Gastric Mucosal Protective Agent Market Size (000 Units) and Y-o-Y Growth
4.5.3. Gastric Mucosal Protective Agent Market Absolute $ Opportunity
5. Global Gastric Mucosal Protective Agent Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Gastric Mucosal Protective Agent Market Size and Volume Forecast by Type
5.3.1. Tablet
5.3.2. Chewable
5.3.3. Injectable
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Gastric Mucosal Protective Agent Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Gastric Mucosal Protective Agent Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Laboratory
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Gastric Mucosal Protective Agent Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Gastric Mucosal Protective Agent Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Gastric Mucosal Protective Agent Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Gastric Mucosal Protective Agent Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Gastric Mucosal Protective Agent Demand Share Forecast, 2019-2026
9. North America Gastric Mucosal Protective Agent Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Gastric Mucosal Protective Agent Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Gastric Mucosal Protective Agent Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Laboratory
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Gastric Mucosal Protective Agent Market Size and Volume Forecast by Type
9.7.1. Tablet
9.7.2. Chewable
9.7.3. Injectable
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Gastric Mucosal Protective Agent Demand Share Forecast, 2019-2026
10. Latin America Gastric Mucosal Protective Agent Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Gastric Mucosal Protective Agent Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Gastric Mucosal Protective Agent Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Laboratory
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Gastric Mucosal Protective Agent Market Size and Volume Forecast by Type
10.7.1. Tablet
10.7.2. Chewable
10.7.3. Injectable
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Gastric Mucosal Protective Agent Demand Share Forecast, 2019-2026
11. Europe Gastric Mucosal Protective Agent Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Gastric Mucosal Protective Agent Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Gastric Mucosal Protective Agent Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Laboratory
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Gastric Mucosal Protective Agent Market Size and Volume Forecast by Type
11.7.1. Tablet
11.7.2. Chewable
1.7.3. Injectable
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Gastric Mucosal Protective Agent Demand Share, 2019-2026
12. Asia Pacific Gastric Mucosal Protective Agent Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Gastric Mucosal Protective Agent Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Gastric Mucosal Protective Agent Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Laboratory
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Gastric Mucosal Protective Agent Market Size and Volume Forecast by Type
12.7.1. Tablet
12.7.2. Chewable
12.7.3. Injectable
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Gastric Mucosal Protective Agent Demand Share, 2019-2026
13. Middle East & Africa Gastric Mucosal Protective Agent Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Gastric Mucosal Protective Agent Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Gastric Mucosal Protective Agent Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Laboratory
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Gastric Mucosal Protective Agent Market Size and Volume Forecast by Type
13.7.1. Tablet
13.7.2. Chewable
13.7.3. Injectable
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Gastric Mucosal Protective Agent Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Gastric Mucosal Protective Agent Market: Market Share Analysis
14.2. Gastric Mucosal Protective Agent Distributors and Customers
14.3. Gastric Mucosal Protective Agent Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Eisai
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pfizer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GSK
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merck
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
